Navigation Links
Determining Valuations in Challenging Times
Date:11/5/2008

icularly through our advisory services and our pan media offerings, PharmaDeals and PharmaTelevision."

Notes to Editors:

About PharmaVentures
PharmaVentures assists pharmaceutical and biotechnology companies across the world in all aspects of deal making. The Company's core business is the provision of tailored transaction advisory services to the Life Science industry, with additional deal making support provided through the PharmaDeals® range of publishing products that include databases, analysis tools, and reports as well as PharmaTelevision, the industry's first dedicated online TV channel. PharmaVentures is based in Oxford, UK, and employs over 35 people. With offices in the USA and Australia, the Company works for a variety of clients from start-ups to global corporate pharmaceutical companies.

www.pharmaventures.com
www.pharmadeals.net
www.pharmatelevision.com

About the Report
The Royalty Rate Report 2009: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector.
A Report by PharmaVentures, Edited by Nigel Borshell
ISBN 978-0-9558821-3-5
Available in print and in electronic format
Table of Contents and Sample Pages
Order Form

Related Video from PharmaTelevision
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. NEJM Report Finds HPV Test More Effective Than Pap in Determining Cervical Cancer Risk
2. CSHL scientists make progress in determining how the brain selectively interprets sound
3. New method proposed for determining which patients should get treatment for colorectal cancer
4. New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer
5. Determining genetic signature of lung tumors can help guide treatment
6. Fitness a Key Element in Determining Male Diabetics Longevity
7. PET/CT scan could be valuable noninvasive tool for determining stages of ovarian cancer
8. Past Earnings Play Role in Determining SSDI Benefits
9. Norwalk virus: Cruise ship illness challenging and costly to hospitals, too
10. National Survey Finds Employers are Challenging Health Plans to Better Use Resources to Prevent Illness and Improve Patient Safety
11. Leading Epilepsy Groups Unveil New Survey Results Challenging Patients to Take Charge of Their Health
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Determining Valuations in Challenging Times 
(Date:6/29/2015)... , ... June 29, 2015 , ... ... developed a new approach to build nearly complete genomes by combining high-throughput DNA ... genomic variation, critically important for their association with human disease, but previously difficult ...
(Date:6/29/2015)... ... 29, 2015 , ... San Fernando Valley skin doctor , Dr. Peyman ... is a special treatment that offers a way to firm sagging facial and neck ... production. Ulthera is highly targeted and precise to help reduce treatment time and improve ...
(Date:6/29/2015)... ... June 29, 2015 , ... The Food Safety and ... The Hong Kong Polytechnic University (PolyU) has developed a new method for rapid ... has been a long-term issue in food safety, and becomes particularly important with ...
(Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... ... HVAC and plumbing company serving the Twin Cities area, provides money-saving tactics during ... efficiency strategies for Twin Cities’ residents, addressing water conservation and other economical practices. ...
(Date:6/29/2015)... ... June 29, 2015 , ... BaliniSports has been announced ... that is taking place later this year. This year’s contestants will be wearing pieces ... the Miss Teen Nevada competition will go on to represent the state in the ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2Health News:Save Energy: MSP Plumbing, Heating & Air Endorses Efficiency 2Health News:Save Energy: MSP Plumbing, Heating & Air Endorses Efficiency 3Health News:BaliniSports Announced as Sponsor of the Miss Teen Nevada 2016 Competition 2
... Nanyang Technological University (NTU) and Insightra Medical of Irvine ... for sale in the United States. This is the ... and patented in accordance with design controls. , ... retractor systems that provides complete retraction flexibility and optimal ...
... Serves Up Insider Tips and Recipes to Enhance Any Dining ... of Acid Wear on Teeth, PITTSBURGH, Oct. 17 Those ... about the toll their diets can sometimes take,on tooth enamel as ... are consuming healthier fare such as fruits, vegetables, diet,sodas and sports ...
... diseases, including Age-Related Macular Degeneration and Diabetic ... ... Charlesson, LLC ("Charlesson"),today announced that it is the recipient of ... Health,(NIH), and an award from the Oklahoma Center for the Advancement ...
... CWA District 6 will,hold a rally on Thursday, October 18, ... Employee Medical Benefits When: October 18, 2007 ... Time: 12 Noon CWA members have failed to ... and AT&T Internet,Services/AT&T Video Services. CWA members are prepared to do ...
... SUPG ), a pharmaceutical company dedicated to ... solid tumors and,hematological malignancies, today announced that multiple ... AACR-NCI-EORTC International,Conference from Oct. 22-26 at the Moscone ... will focus on data concerning many of,SuperGen,s current ...
... China, Oct. 17 /Xinhua-PRNewswire/ -- Mindray Medical,International Limited (NYSE: ... medical devices in China, today announced that it will ... market closes on,November 1, 2007. Mindray,s management will hold ... 2007 U.S. Eastern Time (8:00 AM on November,2, 2007 ...
Cached Medicine News:Health News:NTU and Insightra Medical Inc. release their first joint venture medical device 2Health News:Food 'Pro' Cat Cora Teams Up With Sensodyne(R) ProNamel(TM) to Offer a Guide to Dining out with a Smile 2Health News:Food 'Pro' Cat Cora Teams Up With Sensodyne(R) ProNamel(TM) to Offer a Guide to Dining out with a Smile 3Health News:Ocular Pharma Company Charlesson Announces $2.35MM in New Funding 2Health News:Ocular Pharma Company Charlesson Announces $2.35MM in New Funding 3Health News:Ocular Pharma Company Charlesson Announces $2.35MM in New Funding 4Health News:Ocular Pharma Company Charlesson Announces $2.35MM in New Funding 5Health News:SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference 2Health News:SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference 3Health News:Mindray to Report Third Quarter 2007 Financial Results on November 1, 2007 2
(Date:6/29/2015)... , June 29, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... added to the Russell 1000 Index, effective June 26, ... the large-cap segment of the U.S. equity universe. It ... includes approximately 1000 of the largest securities based on ... membership. "We are pleased to be added ...
(Date:6/29/2015)... Axxess , an industry leader in ... vendor accredited by the American Nursing Credentialing Center – ... agencies select the right revenue cycle management (RCM) system ... business. Research by American Health Information Management ... a decrease in productivity of 54.4 - 69 percent ...
(Date:6/29/2015)... 29, 2015  Arbor Solution has added another ... high-powered, multi-functional M2150 offers two platforms: ... Core i5-4402E 1.6 GHz processor and i5-4422E ... and computing performance. Integrated Intel® HD Graphics 4600 ... suited for graphics-intense applications in operating rooms, clinical ...
Breaking Medicine Technology:ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... N.J., July 05, 2007 /PRNewswire/ -- Results ... open-label, Phase,3 study showed that 77 percent ... 600 mg tablets with,100 mg ritonavir (PREZISTA/r) ... of antiretroviral (ARV) agents, reached a,plasma viral ...
... 2007 - ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces ... II trial of ZIO-201 (isophosphoramide mustard,- IPM) ... at the,European Society of Medical Oncology (ESMO) ... The abstract entitled, "Phase-I/II,Study of IPM (ZIO-201) ...
Cached Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Medicine Products: